César Augusto
Rodríguez Sánchez
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublicaciones en colaboración con investigadores/as de University of North Carolina at Chapel Hill (1)
2016
-
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Breast Cancer Research and Treatment, Vol. 156, Núm. 1, pp. 81-89